Updated October 2026

The Peptide
Benchmark

Independent vendor rankings, peptide price comparison, and evidence-graded research profiles in one place. Source-linked data, not vague claims.

415
Vendors Ranked
9,847
Prices Tracked
137
Peptide Profiles
Daily
Refreshed

Vendor Rankings

Vendors ranked by PeptideBenchmark's own scoring model — combining trust evidence, pricing coverage, and third-party review data from Finnrick, Peptide Critic, and Trustpilot.

Vendors Ranked
415

Vendors with enough evidence to earn a score on the board.

Trust Reviewed
130

Curated vendors with catalog, testing-evidence, and transparency assessments.

Current Trustpilot
75

Active profiles tracked; 2 delisted ratings are retained and labeled as historical.

How scoring works

Each vendor's rank score reflects our own evidence: COA coverage, pricing depth, and third-party trust signals from Trustpilot, Finnrick, and Peptide Critic. External sources contribute as bonus signals, not gatekeepers — a vendor with strong PeptideBenchmark evidence can rank without them.

Open full benchmark board
View All Vendor Reviews →

Peptide Price Comparison

Live, format-aware pricing from 129 tracked vendors. Vials use effective $/mg with modeled codes; ready sprays and capsules keep their labeled-dose configurations; IU products show price per 1,000 IU and are never mixed into milligrams.

129
Vendors tracked
Daily
Price refresh
20%
Max coupon discount
Compare prices Browse coupon codes
Public evidence infrastructureNew

Search the certificate, not the claim.

Find source-linked peptide certificates by vendor, compound, laboratory, batch, tested panel, and verification status.

Explore the COA database

How the vendor and testing layers fit together

Start here if you want the shortest path through the site’s trust architecture. The vendor side shows who exposes transparency well, the testing side shows which labs and platforms anchor that evidence, and the bridge shows where those stories actually meet.

Start here for public verification
Janoshik

Start here if you care most about public report verification that ordinary readers can inspect themselves.

Start here for direct consumer flow
Kovera

Good fit when you want a more direct-consumer testing flow with visible pricing and shareable verification behavior.

Start here for classic lab profiles
Freedom / ILS

Better fit when you want classic analytical-lab framing instead of a platform-style public results experience.

Open vendor compare Open testing compare Open bridge view Browse testing directory

Peptides by research area

Explore compounds organized by research area — metabolic, tissue-repair, GH axis, and more — with regulatory context and evidence notes on each profile.

🧪
Hormone signaling research
42 profiles
Hormone-linked signaling compounds that do not fit cleanly into the GH or metabolic buckets.
⚖️
Metabolic / incretin research
23 profiles
GLP-1 agonists, dual agonists, triple agonists, and related metabolic signaling compounds.
🩹
Tissue-repair research
21 profiles
Tissue-repair, soft-tissue, and gut-oriented peptides commonly discussed in regenerative research contexts.
•
Longevity
19 profiles
Research-area coverage will expand here as more profiles are published.
•
Other research areas
19 profiles
Useful overflow for compounds that do not belong to the main editorial buckets.
💪
Performance / anabolic research
18 profiles
Performance-adjacent peptides and growth-factor analogs that usually sit outside labeled medical use.
🛡️
Immune / inflammation research
17 profiles
Immune-oriented peptides with more clinical framing than the average research-market profile.
✨
Dermal / cosmetic research
16 profiles
Copper peptides, regenerative signaling compounds, and dermal-facing entries with cosmetic crossover.
🧬
Longevity research
15 profiles
Longevity-facing compounds where mechanism, speculation, and marketing often collide.
•
Metabolic
15 profiles
Research-area coverage will expand here as more profiles are published.
•
Neuroprotection
15 profiles
Research-area coverage will expand here as more profiles are published.
📈
GH axis / secretagogue research
13 profiles
GHRH analogs and secretagogues studied in the growth-hormone axis literature.
🧠
Cognitive / nootropic research
13 profiles
Cognitive and neuropeptide-oriented compounds that are popular online but often weakly explained.
•
Cardiovascular
10 profiles
Research-area coverage will expand here as more profiles are published.

Trending Peptides

Current profile coverage pulled directly from the peptide collection, mixing FDA-approved medicines with closely watched research compounds.

🔥 HOT
Metabolic
Retatrutide
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors, showing unprecedented 24.2% weight loss in clinical trials. Expected FDA approval in 2027.
Investigational 1 alias
Trials 35PubMed 197 Medium context
Triple AgonistPhase 3GLP-1GIP
🔥 HOT
Metabolic
Semaglutide
A GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes, chronic weight management, and additional labeled uses depending on brand and indication.
FDA Approved 3 aliases
FDATrials 801PubMed 5.7K High context
GLP-1FDA ApprovedWeight ManagementType 2 Diabetes
🔥 HOT
Metabolic
Tirzepatide
A dual GIP and GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes and chronic weight management.
FDA Approved 2 aliases
FDATrials 318PubMed 2.6K High context
GIPGLP-1FDA ApprovedWeight Management
Tissue repair
BPC-157
A 15-amino acid peptide derived from human gastric juice, extensively studied for tissue regeneration, gut healing, and injury recovery across multiple systems.
Research Market 2 aliases
Also in Performance
Trials 4PubMed 222 Medium context
HealingGut HealthTendon RepairRecovery
🔥 HOT
Metabolic
CagriSema
A Novo Nordisk investigational combination of cagrilintide and semaglutide, designed to pair amylin and GLP-1 pathways in obesity.
Investigational
Also in Hormone
Trials 31PubMed 56 Medium context
CagrilintideSemaglutideAmylinGLP-1
GH axis
Tesamorelin
A growth hormone-releasing hormone analog approved in the United States for reducing excess abdominal fat in certain adults with HIV-associated lipodystrophy.
FDA Approved 2 aliases
Also in Performance
FDATrials 24PubMed 94 High context
GHRHFDA ApprovedBody CompositionHIV Lipodystrophy

From the Blog

Collection-backed notes on benchmark methodology, source quality, and how to interpret peptide vendor signal without overclaiming certainty.

View All Posts →